For media inquiries, visit the Office of Media Relations website or call 702-895-3102.
Newsletter Subscription
Want to see how UNLV is covered in national and local media outlets? Subscribe to the Office of Media Relations' "UNLV In The News" newsletter for top headlines. It is emailed to subscribers on weekdays. Submit the form below to subscribe.
If you’re vaccinated and wondering whether you should butt in and try to persuade others to get vaccinated, too, you’re not alone.
Now that the FDA has approved Biogen's aducanumab (Aduhelm), the controversial new drug for Alzheimer's disease, what does this mean?
From just 1,200 cases spread out over 18 months, Taiwan now tops 10,000. Though low compared to other parts of East Asia, it has been a major confidence blow as Taiwan has been hailed globally for its successful strategy in keeping COVID-19 at bay.
In a watershed moment for the field, the U.S. Food and Drug Administration yesterday approved the first Alzheimer’s treatment that tackles the underlying disease pathology.
The first drug to treat Alzheimer’s disease in 18 years, which was extensively researched at the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, has won approval from the Food and Drug Administration.
Progressives are livid at Sen. Joe Manchin, D-W.V. — once again.
Danica Hays is helping build the teacher of tomorrow at UNLV, and she’s not bashful in saying it’s a community effort.
SpaceX launched thousands of tiny sea creatures to the International Space Station on Thursday, along with a plaque-fighting toothpaste experiment and powerful solar panels.
The nation’s first big convention since the onset of the coronavirus pandemic kicked off this week in Las Vegas. Tourism experts hope the World of Concrete event will spur the city’s casino-based economy.